20
Participants
Start Date
September 11, 2023
Primary Completion Date
December 1, 2025
Study Completion Date
December 1, 2025
Empagliflozin 10 MG
Participants will be randomized to Empagliflozin 10 mg or placebo for 14 days. A 14 day washout period follows and then participants is crossed over to the alternate treatment for 14 days.
Matching Placebo
Participants will be randomized to Empagliflozin 10 mg or placebo for 14 days. A 14 day washout period follows and then participants is crossed over to the alternate treatment for 14 days.
RECRUITING
Yale University, New Haven
Collaborators (1)
Boehringer Ingelheim
INDUSTRY
Yale University
OTHER